 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bfrost@merge.com
|
|
Michael D. Dunham, Chairman of the Board
Merge Healthcare
414.977.4000
|
|
Merge Technologies Files Annual Report for Full Year 2005 and Quarterly Report for First Quarter of 2006, and Requests Extension from NASDAQ for Filing of Report for Second
Milwaukee, WI, August 30, 2006 (5:30 AM CDT) - Merge Technologies Incorporated, d.b.a. Merge Healthcare (NASDAQ: MRGE; TSX: MRG), today filed, prior to the market opening, its Annual Report on Form 10-K for the year ended December 31, 2005 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2006. As previously announced, NASDAQ determined to continue the listing of the Company’s common stock on the NASDAQ Global Market subject to the Company’s filing of these reports, along with all required restatements, by no later than August 29, 2006. The Company is seeking confirmation from NASDAQ that the filing of these reports from this morning, prior to the market opening, will be satisfactory to NASDAQ. The Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 and has requested that NASDAQ grant the Company an additional extension until September 8, 2006, to regain compliance with the NASDAQ listing requirements by filing the second quarter 2006 Form 10-Q. The Company expects that it will file that Form 10-Q by no later than this requested additional extension date.
Management plans to conduct a financial and operational update conference call promptly after the Company files its second quarter 2006 Form 10-Q.
The 2005 Form 10-K and 2006 Q1 Form 10-Q are available at: http://www.mergehealthcare.com/investorrelations/index.htm (Click on Real-Time Filings).
###
Merge Healthcare is a market leader in the development and delivery of medical imaging and
information management software and services. Our innovative software solutions use leading-edge
imaging software technologies that accelerate market delivery for our OEM customers, while our enduser
solutions improve our customers' productivity and enhance the quality of patient care they
provide. For additional information, visit our website at www.merge.com.
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forwardlooking statements. Actual results could differ materially from those expressed in, or implied by, the forwardlooking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The Nasdaq Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The Nasdaq Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
